Published in Lancet on March 13, 2010
Sympathetic Activity and Cardiometabolic Complications (SYMPACT) | NCT04495231
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study. Ann Intern Med (2015) 2.42
Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol (2010) 2.12
Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: rationale and design of the EARNEST study. Am Heart J (2013) 2.07
Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in African Americans. Hypertens Res (2011) 2.03
Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association. Hypertension (2015) 2.01
Assessment and management of blood-pressure variability. Nat Rev Cardiol (2013) 1.84
Presence of baseline prehypertension and risk of incident stroke: a meta-analysis. Neurology (2011) 1.64
Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease. J Hypertens (2016) 1.61
A blood pressure genetic risk score is a significant predictor of incident cardiovascular events in 32,669 individuals. Hypertension (2013) 1.60
Outdoor temperature, blood pressure, and cardiovascular disease mortality among 23 000 individuals with diagnosed cardiovascular diseases from China. Eur Heart J (2015) 1.59
Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension (2014) 1.55
Relationship between inter-arm difference in systolic blood pressure and arterial stiffness in community-dwelling older adults. J Clin Hypertens (Greenwich) (2013) 1.51
Pulsatile and steady components of blood pressure and subclinical cerebrovascular disease: the Northern Manhattan Study. J Hypertens (2015) 1.48
Detecting major genetic loci controlling phenotypic variability in experimental crosses. Genetics (2011) 1.46
Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative. Hypertension (2012) 1.46
The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials. J Hypertens (2014) 1.45
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes (2014) 1.44
Impact of intraoperative hypotension and blood pressure fluctuations on early postoperative delirium after non-cardiac surgery. Br J Anaesth (2015) 1.44
Patients' experiences of self-monitoring blood pressure and self-titration of medication: the TASMINH2 trial qualitative study. Br J Gen Pract (2012) 1.44
Visit-to-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension. Am J Hypertens (2012) 1.35
Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis. Hypertension (2014) 1.25
Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care. J Hypertens (2011) 1.23
Association between antihypertensive medication adherence and visit-to-visit variability of blood pressure. J Clin Hypertens (Greenwich) (2012) 1.21
Blood pressure trajectories and associations with treatment intensification, medication adherence, and outcomes among newly diagnosed coronary artery disease patients. Circ Cardiovasc Qual Outcomes (2010) 1.19
Personality traits as risk factors for stroke and coronary heart disease mortality: pooled analysis of three cohort studies. J Behav Med (2013) 1.18
Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics (2011) 1.16
Stroke patients' perceptions of home blood pressure monitoring: a qualitative study. Br J Gen Pract (2011) 1.16
Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care (2013) 1.16
Home blood pressure variability as cardiovascular risk factor in the population of Ohasama. Hypertension (2012) 1.11
Associations of aortic distensibility and arterial elasticity with long-term visit-to-visit blood pressure variability: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens (2013) 1.10
Low birth weight is associated with higher blood pressure variability from childhood to young adulthood: the Bogalusa Heart Study. Am J Epidemiol (2012) 1.09
Blood pressure variability and cardiovascular risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS One (2012) 1.03
Association of BP variability with mortality among African Americans with CKD. Clin J Am Soc Nephrol (2013) 1.03
Heart Rate and Systolic Blood Pressure Variability in the Time Domain in Patients with Recent and Long-Standing Diabetes Mellitus. PLoS One (2016) 1.02
Redefined blood pressure variability measure and its association with mortality in elderly primary care patients. Hypertension (2014) 1.01
Blood pressure levels and stroke: J-curve phenomenon? Curr Hypertens Rep (2013) 1.00
Within-subject blood pressure level--not variability--predicts fatal and nonfatal outcomes in a general population. Hypertension (2012) 1.00
Psychological aspects of diabetes care: Effecting behavioral change in patients. World J Diabetes (2014) 0.99
Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis. J Hum Hypertens (2013) 0.99
The role of blood pressure variability in the development of nephropathy in type 1 diabetes. Diabetes Care (2010) 0.99
Visit-to-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes. Diabetes Care (2013) 0.98
Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study. Am J Hypertens (2013) 0.97
Impact of one or two visits strategy on hypertension burden estimation in HYDY, a population-based cross-sectional study: implications for healthcare resource allocation decision making. BMJ Open (2012) 0.96
Adult hypertension is associated with blood pressure variability in childhood in blacks and whites: the bogalusa heart study. Am J Hypertens (2010) 0.96
Predialysis systolic BP variability and outcomes in hemodialysis patients. J Am Soc Nephrol (2014) 0.95
Blood pressure measurement: clinic, home, ambulatory, and beyond. Am J Kidney Dis (2012) 0.94
Current perspectives on combination therapy in the management of hypertension. Integr Blood Press Control (2013) 0.92
Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ (2016) 0.91
Current challenges in the clinical management of hypertension. Nat Rev Cardiol (2011) 0.89
Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study. Lancet Neurol (2014) 0.89
Systolic hypertension: an increasing clinical challenge in Asia. Hypertens Res (2014) 0.88
Association of circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal function. Clin J Am Soc Nephrol (2012) 0.88
Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses. Curr Hypertens Rep (2013) 0.88
Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions. Int J Stroke (2015) 0.87
Clinical relevance of visit-to-visit blood pressure variability: impact on renal outcomes. J Hum Hypertens (2013) 0.87
Hypertension: empirical evidence and implications in 2014. Open Heart (2014) 0.87
Visit-to-visit and 24-h blood pressure variability: association with endothelial and smooth muscle function in African Americans. J Hum Hypertens (2013) 0.87
The clinical association of the blood pressure variability with the target organ damage in hypertensive patients with chronic kidney disease. J Korean Med Sci (2014) 0.86
Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives. Endocrinol Metab Clin North Am (2013) 0.86
Effects of Renal Sympathetic Denervation on 24-hour Blood Pressure Variability. Front Physiol (2012) 0.86
Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Clin Hypertens (Greenwich) (2014) 0.85
Hypertension in hemodialysis patients: an opinion-based update. Semin Dial (2014) 0.85
Heterogeneity of prognostic studies of 24-hour blood pressure variability: systematic review and meta-analysis. PLoS One (2015) 0.84
Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT. Clin J Am Soc Nephrol (2016) 0.84
A prospective study of variability in systolic blood pressure and mortality in a rural Bangladeshi population cohort. Prev Med (2013) 0.84
Association between ambient temperature and blood pressure and blood pressure regulators: 1831 hypertensive patients followed up for three years. PLoS One (2013) 0.83
Low correlation between visit-to-visit variability and 24-h variability of blood pressure. Hypertens Res (2013) 0.83
Stimulus response of blood pressure in black and white young individuals helps explain racial divergence in adult cardiovascular disease: the Bogalusa Heart Study. J Am Soc Hypertens (2011) 0.83
Medication adherence and visit-to-visit variability of systolic blood pressure in African Americans with chronic kidney disease in the AASK trial. J Hum Hypertens (2015) 0.83
Systolic Blood Pressure Variability is a Novel Risk Factor for Rebleeding in Acute Subarachnoid Hemorrhage: A Case-Control Study. Medicine (Baltimore) (2016) 0.83
Genome-wide analysis of blood pressure variability and ischemic stroke. Stroke (2013) 0.83
The case for home monitoring in hypertension. BMC Med (2010) 0.83
Chinese Herbal Medicine Combined with Conventional Therapy for Blood Pressure Variability in Hypertension Patients: A Systematic Review of Randomized Controlled Trials. Evid Based Complement Alternat Med (2015) 0.83
Hypertension and chronic kidney disease progression: why the suboptimal outcomes? Am J Med (2012) 0.83
Cognitive dysfunction and greater visit-to-visit systolic blood pressure variability. J Am Geriatr Soc (2013) 0.83
Exploring haemodynamics of haemodialysis using extrema points analysis model. Theor Biol Med Model (2013) 0.81
Home and office blood pressure monitoring in renal transplant recipients. J Transplant (2012) 0.81
The impact of blood pressure variability on subclinical ventricular, renal and vascular dysfunction, in patients with hypertension and diabetes. Maedica (Buchar) (2013) 0.81
Pre-dialysis systolic blood pressure-variability is independently associated with all-cause mortality in incident haemodialysis patients. PLoS One (2014) 0.81
Central artery stiffness, baroreflex sensitivity, and brain white matter neuronal fiber integrity in older adults. Neuroimage (2015) 0.81
Short-term blood pressure variability over 24 h and target organ damage in middle-aged men and women. J Hum Hypertens (2015) 0.81
Effect of change in systolic blood pressure between clinic visits on estimated 10-year cardiovascular disease risk. J Am Soc Hypertens (2013) 0.81
The effect of antihypertensive treatment on headache and blood pressure variability in randomized controlled trials: a systematic review. J Neurol (2012) 0.81
Lowering of blood pressure for recurrent stroke prevention. Stroke (2014) 0.81
Hemodynamic Aging as the Consequence of Structural Changes Associated with Early Vascular Aging (EVA). Aging Dis (2014) 0.81
The relationship between the 24 h blood pressure variability and carotid intima-media thickness: a compared study. Comput Math Methods Med (2014) 0.81
Response of day-to-day home blood pressure variability by antihypertensive drug class after transient ischemic attack or nondisabling stroke. Stroke (2014) 0.81
Variation in resting heart rate over 4 years and the risks of myocardial infarction and death among older adults. Heart (2014) 0.80
The effects of weight loss and salt reduction on visit-to-visit blood pressure variability: results from a multicenter randomized controlled trial. J Hypertens (2014) 0.80
Cognitive and kidney function: results from a British birth cohort reaching retirement age. PLoS One (2014) 0.80
Effects of single pill-based combination therapy of amlodipine and atorvastatin on within-visit blood pressure variability and parameters of renal and vascular function in hypertensive patients with chronic kidney disease. Biomed Res Int (2014) 0.80
Cardiac output, blood pressure variability, and cognitive decline in geriatric cardiac patients. J Cardiopulm Rehabil Prev (2011) 0.80
Visit-to-visit blood pressure variability is related to albuminuria variability and progression in patients with type 2 diabetes. J Hum Hypertens (2013) 0.80
The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Hypertension (2016) 0.80
Association of long-term blood pressure variability and brachial-ankle pulse wave velocity: a retrospective study from the APAC cohort. Sci Rep (2016) 0.80
Sex differences in autonomic function following maximal exercise. Biol Sex Differ (2015) 0.80
Measurement-to-measurement blood pressure variability is related to cognitive performance: the Maine Syracuse study. Hypertension (2014) 0.80
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ (2004) 7.92
Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension (2007) 5.61
Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet (2007) 5.21
Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension (2005) 5.05
Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med (2003) 4.59
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol (2010) 3.93
Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet (2010) 3.53
Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension (2006) 3.42
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32
Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension (2013) 2.89
Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol (2010) 2.77
The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure. Eur Heart J (2008) 2.65
Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension (2010) 2.64
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). Diabetes Care (2005) 2.59
Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice. Heart (2010) 2.51
The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the U.K. Eur Heart J (2011) 2.43
Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension (2011) 2.33
Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension (2009) 2.28
Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens (2010) 2.28
Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension (2006) 2.19
Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial). J Am Coll Cardiol (2009) 2.19
Treating individuals 3: from subgroups to individuals: general principles and the example of carotid endarterectomy. Lancet (2005) 1.96
Making ambulatory blood pressure monitoring accessible in pharmacies. Blood Press Monit (2014) 1.95
Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis (2009) 1.94
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens (2004) 1.87
Blood pressure and urinary sodium in men and women: the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk). Am J Clin Nutr (2004) 1.86
Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol (2012) 1.82
Self-measured versus ambulatory blood pressure in the diagnosis of hypertension. J Hypertens (2003) 1.78
Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol (2010) 1.76
Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial. Am J Hypertens (2010) 1.75
Structure-based design of aliskiren, a novel orally effective renin inhibitor. Biochem Biophys Res Commun (2003) 1.74
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72
Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial. Eur Heart J (2011) 1.66
Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. Am Heart J (2013) 1.62
The International Database of Ambulatory Blood Pressure in relation to Cardiovascular Outcome (IDACO): protocol and research perspectives. Blood Press Monit (2007) 1.62
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes. J Hypertens (2008) 1.61
A new solar-powered blood pressure measuring device for low-resource settings. Hypertension (2010) 1.61
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58
Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial. Eur Heart J (2006) 1.58
Improvement in hypertension management in England: results from the Health Survey for England 2003. J Hypertens (2006) 1.57
Blood pressure variability: clarity for clinical practice. Hypertension (2010) 1.55
Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin: a cohort analysis from the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm. J Am Coll Cardiol (2013) 1.54
Ethnicity and left ventricular diastolic function in hypertension an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy. J Am Coll Cardiol (2008) 1.51
Impact of applying the more stringent validation criteria of the revised European Society of Hypertension International Protocol 2010 on earlier validation studies. Blood Press Monit (2011) 1.50
Outcome-driven thresholds for ambulatory pulse pressure in 9938 participants recruited from 11 populations. Hypertension (2013) 1.50
Risk stratification by 24-hour ambulatory blood pressure and estimated glomerular filtration rate in 5322 subjects from 11 populations. Hypertension (2012) 1.49
Angiotensin receptor blockers: therapeutic targets and cardiovascular protection. Blood Press (2005) 1.49
Determinants of the ambulatory arterial stiffness index in 7604 subjects from 6 populations. Hypertension (2008) 1.48
Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk. J Hypertens (2011) 1.47
Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs. Hypertens Res (2011) 1.47
The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure level in adults. J Hypertens (2006) 1.46
Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren. Hypertension (2003) 1.46
First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. Int J Cardiol (2012) 1.45
Serum lipids associated with inflammation-related PET-FDG uptake in symptomatic carotid plaque. Neurology (2014) 1.45
Blood pressure loci identified with a gene-centric array. Am J Hum Genet (2011) 1.44
Blood pressure load does not add to ambulatory blood pressure level for cardiovascular risk stratification. Hypertension (2014) 1.44
The value of N-terminal pro-B-type natriuretic peptide in determining antihypertensive benefit: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Hypertension (2013) 1.44